TEBENTAFUSP

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 13:58:38 GMT 2023` Edited by `admin` on `Sat Dec 16 13:58:38 GMT 2023`
Protein Type	FC FUSION PROTEIN
Protein Sub Type	T-CELL ANTIGEN
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	N658GY6L3E
Record Status	`Validated (UNII)`
Record Version

Download

Related Record	Type

Name

Type

Language

TEBENTAFUSP

Official Name

English

Tebentafusp [WHO-DD]

Common Name

English

IMCGP-100

Code

English

T CELL RECEPTOR .ALPHA. CHAIN (SYNTHETIC HUMAN) FUSION PROTEIN WITH T CELL RECEPTOR .BETA. CHAIN (SYNTHETIC HUMAN) FUSION PROTEIN WITH IMMUNOGLOBULIN, ANTI-(HUMAN CD3 ANTIGEN) (SYNTHETIC SCFV FRAGMENT)

Common Name

English

tebentafusp [INN]

Common Name

English

IMMTAC IMCGP100

Code

English

IMCGP100

Code

English

TEBENTAFUSP [USAN]

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

503615

Created by admin on Sat Dec 16 13:58:38 GMT 2023 , Edited by admin on Sat Dec 16 13:58:38 GMT 2023

Code System Code Type Description

FDA UNII

N658GY6L3E

Created by admin on Sat Dec 16 13:58:38 GMT 2023 , Edited by admin on Sat Dec 16 13:58:38 GMT 2023

PRIMARY

USAN

GH-27

Created by admin on Sat Dec 16 13:58:38 GMT 2023 , Edited by admin on Sat Dec 16 13:58:38 GMT 2023

PRIMARY

CAS

1874157-95-5

Created by admin on Sat Dec 16 13:58:38 GMT 2023 , Edited by admin on Sat Dec 16 13:58:38 GMT 2023

PRIMARY

INN

10664

Created by admin on Sat Dec 16 13:58:38 GMT 2023 , Edited by admin on Sat Dec 16 13:58:38 GMT 2023

PRIMARY

NCI_THESAURUS

C94208

Created by admin on Sat Dec 16 13:58:38 GMT 2023 , Edited by admin on Sat Dec 16 13:58:38 GMT 2023

PRIMARY

DAILYMED

N658GY6L3E

Created by admin on Sat Dec 16 13:58:38 GMT 2023 , Edited by admin on Sat Dec 16 13:58:38 GMT 2023

PRIMARY

RXCUI

2590743

Created by admin on Sat Dec 16 13:58:38 GMT 2023 , Edited by admin on Sat Dec 16 13:58:38 GMT 2023

PRIMARY

DRUG BANK

DB15283

Created by admin on Sat Dec 16 13:58:38 GMT 2023 , Edited by admin on Sat Dec 16 13:58:38 GMT 2023

PRIMARY

From	To
1_23	1_88
1_153	1_227
1_281	1_349
1_401	1_466
1_427	2_157
2_23	2_89
2_132	2_182

Related Record Type Details


					ZLW14X2D30

CD3

TARGET -> AGONIST

Interaction Type:

BINDING


					1NU720978F

TARGET->ANTIGEN

Comments:

HLA-A2 restricted melanoma gp100 peptide (YLEPGPVTA)

Amount:

TEBENTAFUSP-TEBN

SUB_CONCEPT->SUBSTANCE

Amount:

Related Record Type Details


					N658GY6L3E

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL